title: Clonazepam for the treatment of social phobia.
abstract: Nine of 11 patients with social phobia of both the generalized and performance type responded to treatment with clonazepam in total daily doses ranging from 0.75 to 3 mg. Only 2 of these 9 had comorbid panic disorder; the benefit for social phobic symptoms appears independent of clonazepam's putative efficacy for panic disorder.
authors.affiliation: Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
authors.forename: S R
authors.initials: SR
authors.lastname: Reiter
authors.forename: M H
authors.initials: MH
authors.lastname: Pollack
authors.forename: J F
authors.initials: JF
authors.lastname: Rosenbaum
authors.forename: L S
authors.initials: LS
authors.lastname: Cohen
mesh_terms: D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy / Q000453:epidemiology; D002998:Clonazepam / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D010200:Panic; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales
chemical_list: D002998:Clonazepam